• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

SARS-CoV-2 RNA Frequently Found in Blood Donor Plasma is Not Infectious

September 7, 2022

Although no cases of SARS-CoV-2 transfusion-transmission have been reported worldwide, RNA is detected in 15% to 90% of patients with critical COVID-19 and 2% to 13% of individuals with mild COVID-19 symptoms.  A study recently published in The Journal of Clinical Investigation adds to the growing body of evidence that the risk of transfusion-transmission is very low.  From January 2020 through July 2021, four major blood collection centers (representing approximately 50% of the U.S. blood supply) investigated infectivity of 2,250 blood samples collected from individuals who self-reported post-donation COVID-19 infections and/or symptoms.  Overall, 196 (8.7%) were RNA positive for SARS-CoV-2.  One percent of samples were positive starting in March 2020; positivity peaked at 9% in September 2020 and 15% in March 2021, and fell to 4% in April 2021 after the introduction of widespread vaccination.  The median SARS-CoV-2 viral load was estimated to be very low—6 gEq/mL— with 90% of samples having an estimated viral load of 18 gEq/mL or lower. Both cell culture and mouse models of infection found that viral loads needed to be multiple log-folds higher to be infectious via blood transfusions.  These results suggest that SARS-CoV-2 is not transfusion transmissible and support the policy of not testing blood products for SARS-CoV-2.

Reference:

Saá, P, Fink RV, Bakkour S, Jin J, et al.  Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasma.  The Journal of Clinical Investigation 2022; 132(17); e159876.

Filed Under

  • News
  • Transfusion Transmitted Infections

Recommended

  • Donor Red Cell Metabolites May Be Correlated with Post-transfusion RBC Survival

  • The BEST Criteria to Decide Whether or Not to Culture Suspected Blood Components

  • No Transfusion-Transmission of Classic Creutzfeldt-Jakob Disease

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Acute Normovolemic Hemodilution Does Not Reduce RBC Transfusions

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

  • Plasma Exchange to Reduce Biological Age

  • New Guidelines for Platelet Transfusion Recommend Restrictive Strategies

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley